课题基金 / 基金详情

CORRECTION OF INHERITED PROTEIN DEFICIENCIES BY GENE THERAPY

CORRECTION OF INHERITED PROTEIN DEFICIENCIES BY GENE THERAPY
通过基因疗法纠正遗传性蛋白质缺陷
批准号:
3859899
负责人:
E I GINNS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

E I GINNS的其他基金

相关文献

中文摘要
翻译
正常与异常蛋白的分离与鉴定
英文摘要
The isolation and characterization of normal and abnormal proteins in genetic disorders affecting the nervous system permits the isolation of cDNA and genomic DNA that can be used to correct inherited protein deficiencies using gene therapy. Particularly suited for initial attempts at gene therapy are those disorders (such as Gaucher disease, the most common sphingolipidosis) in which the systemic and neurologic manifestations of the disorder are the consequences of abnormalities of hematopoietic cells, like the macrophage. In these instances that transfer of normal genes to either specific tissue or bone marrow progenitor cells is a rationale therapeutic approach. Using the lysosomal disorder Gaucher disease as a model, we utilized retroviral vectors to transfer and express human glucocerebrosidase in mouse and Gaucher patient cell lines. The complete correction of glucocerebrosidase activity in Gaucher fibroblasts in culture has provided the impetus for evaluation of retroviral mediated gene transfer of the glucocerebrosidase gene into a mouse model of Gaucher disease. Retroviral mediated transfer of tyrosine hydroxylase for the correction of DOPA deficiency states is also studied. Receptor mediated gene transfer into tissues is also being investigated. The initial goal of this research is the application of gene therapy to the non-neuronopathic phenotypes. Transgenic animal models are developed using targeted homologous recombination in embryonic stem cells to generate mouse models of human disease. Recombinantly manipulated cells that act as depots of L- DOPA release are used for transplantation into the nervous system of animal models. When our understanding of the pathogenic mechanisms of inherited neurological and psychiatric diseases improves and as retroviral-mediated expression of genes in specific tissues and cells becomes more predictable, we can extend the use of gene therapy to treatment of selected disorders affecting the nervous system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR GENETICS OF LYSOSOMAL DISORDERS
MOLECULAR GENETIC STUDIES OF THE MUCOPOLYSACCHARIDOSES
TRANSGENIC ANIMAL MODELS OF HUMAN INHERITED DISORDERS
STUDIES OF GAUCHER DISEASE AND OTHER NEUROGENETIC DISORDERS TOWARD GENE THERAPY